Population Pharmacokinetic Study of Tacrolimus in Pediatric Patients with Primary Nephrotic Syndrome: A Comparison of Linear and Nonlinear Michaelis Menten Pharmacokinetic Model
Lingfei Huang, Yixi Liu, Zheng Jiao, Junyan Wang, Luo Fang, Jianhua, Mao

TL;DR
This study compares linear and nonlinear pharmacokinetic models for tacrolimus in children with primary nephrotic syndrome, finding the nonlinear Michaelis Menten model more accurate for guiding dosing adjustments.
Contribution
It introduces a nonlinear Michaelis Menten pharmacokinetic model for tacrolimus in pediatric PNS, outperforming traditional linear models in predictive accuracy.
Findings
Nonlinear model better predicts tacrolimus PK in children.
Body weight, co-therapy drugs, and CYP3A5*3 genotype are key factors.
Proposed dosing regimens based on nonlinear PK model.
Abstract
Background Little is known about the population pharmacokinetics (PPK) of tacrolimus (TAC) in pediatric primary nephrotic syndrome (PNS). This study aimed to compare the predictive performance between nonlinear and linear PK models and investigate the significant factors of TAC PK characteristics in pediatric PNS. Methods Data were obtained from 71 pediatric patients with PNS, along with 525 TAC trough concentrations at steady state. The demographic, medical, and treatment details were collected. Genetic polymorphisms were analyzed. The PPK models were developed using nonlinear mixed effects model software. Two modeling strategies, linear compartmental and nonlinear Michaelis Menten (MM) models, were evaluated and compared. Results Body weight, age, daily dose of TAC, co-therapy drugs (including azole antifungal agents and diltiazem), and CYP3A5*3 genotype were important factors in the…
Peer Reviews
No public reviews on file for this paper yet. If you reviewed it on a platform where reviews are public (OpenReview, ICLR, NeurIPS, ICML), you can paste yours below so the community can read it here.
Videos
No videos yet. Explain this paper in a talk, walkthrough, or lecture? Add one.
